You may have seen that the Israeli MoH claims that Pfizer vaccine efficacy has dropped to 64% in Israel, concurrent with the rise of the Delta variant.
The MoH has now published more details on the methodology. Briefly: negative binomial regression controlling for week and age.
In my opinion this leaves *a lot* of potential confounders unaccounted for. Vaccination rates in Israel have converged to 70-90%, with older ppl generally more vaccinated.
There are many potential differences between vaccinated and unvaccinated people. There are further differences in their inclination and formal incentives for being tested for COVID. All of these are not accounted for in the analysis.
I do not claim to know the true vaccine efficacy vs. the Delta variant. However, I am afraid that the current Israeli MoH analysis cannot be used to safely assess it, one way or another.
In recent days two new pieces of evidence have come out of Israel about the effect of the vaccination drive, showing good news about both individual-level and national level effects.
1/7
One is a study from Maccabi HMO (link further in the thread).
The other is one I’m a part of w/ @H_Rossman@GorfineMalka and @segal_eran , and is explained in the thread here:
A while ago I discussed the distinction between vaccines' effects on an individual level vs. the national level.
Even if vaccines protect individuals, that's not enough to protect an entire community, due to uneven distribution and uneven effectiveness
I’m seeing many discussions about the evidence for vaccine effectiveness in Israel. This is a thread with my thoughts on what we know and don’t know at this point. First some vaccination statistics:
Israel has been vaccinating at a fast pace - by today 78% of people aged 60+ have received at least 1 dose, 58% of 60+ are >14 days from their 1st dose, and 30% already received their 2nd dose.
We are all waiting to see how the vaccine effect plays out in a real-world, country-wide setting.
When considering vaccine effectiveness we should separate between two related aspects:
3/18
We’ve noticed something that looks like a potentially important data-entry problem regarding comorbidities in the “big” China CDC report on the Epidemiological Characteristics of COVID19. This report uses data from 72,314 patient records. (1/6)
The China CDC report has the most widely used numbers I’ve seen for age and sex fatality rates. It was reported in brief form in JAMA, and fully in a China CDC weekly (link below, it loads slowly sometimes). weekly.chinacdc.cn/en/article/id/…
(2/6)
See numbers here.
From the report:
“† The comorbid condition variable, only includes a total of 20,812 patients and 504 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.”
(3/6)